Home
Uitgevers
Categorieën
Trending
Inbox

Account aanmaken
Aanmelden

- English
- Deutsch

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Klik hier om u te abonneren op Niaid.nih.gov

Laden...

8 maanden geleden

Html
Tekst

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial 03/20/2024 01:00 PM EDT
Dry AMD affects part of the eyes retina that allows for clear central vision.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Deel deze op

Laden...

Andere nieuwsbrieven van Niaid.nih.gov

HRSA Supports Rural Health Care Niaid.nih.gov
Afgelopen vrijdag om 18:07
New savings available for 2025 health coverage Niaid.nih.gov
Afgelopen vrijdag om 15:44
Biden-Harris Administration Announces $52 Million Investment for Health Cen ters to Provide Care for People Reente ring the Community after Incarceration Niaid.nih.gov
Afgelopen vrijdag om 14:54

Meer nieuwsbrieven van Niaid.nih.gov

Laden...

Gerelateerde nieuwsbrieven

© 2024

Algemene voorwaarden
Privacy

Home
Uitgevers
Categorieën
Trending
Inbox

Account aanmaken
Aanmelden

© 2024

Algemene voorwaarden
Privacy

- English
- Deutsch